Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Neuro-Ophthalmology
•
Endocrinology
•
Thyroid Disorders
•
Oculoplastic Surgery
•
Primary Care
How often and in what way do you monitor patients who are receiving teprotumumab (Tepezza) for thyroid eye disease?
Related Questions
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
How often should TSH levels be monitored in patients with a history of Graves' disease who are in remission with negative TSI/TBII antibodies and off medical therapy?
Which brand/preparation of levothyroxine do you recommend to treat hypothyroid patients with alpha-gal allergy?
How do you assess and adjust treatment in patients who develops hypothyroidism after being on lithium for several years?
How often do you refer patients with hypothyroidism and Type D personality traits, characterized by worry and pessimism, to psychiatry after prescribing standard hypothyroidism treatment?
Would you recommend changing a patient from the pill form of levothyroxine to Tirosint-SOL if they are started on a proton pump inhibitor?
What workup do you recommend for patients requiring higher-than-expected levothyroxine doses for their weight?
How soon after radioactive iodine therapy for hyperthyroidism should Methimazole be resumed?
Is a target TSH closer to the mid normal range justified in older individuals (age 70 or above) without any known cardiac ischemia or dysrhythmia or osteoporosis?
How do you approach treatment of depression in Graves' Disease?
